U.S. International Trade Commission Denies Review of Initial Determination on Tirzepatide Products

Summary

The U.S. International Trade Commission has decided not to review an initial determination finding certain products containing tirzepatide and others purporting to contain tirzepatide to be in violation of Section 337, and requests written submissions on remedy, public interest, and bonding.